The traditional approach to cancer treatment often involves a one-size-fits-all methodology, which may not be effective for all patients. Molecular oncology provides insights into the genetic mutations and pathways involved in cancer, allowing for more precise and individualized interventions. By identifying specific biomarkers, it is possible to predict how a patient will respond to certain therapies, ultimately improving outcomes and minimizing adverse effects.
